Literature DB >> 20038233

Managing tumor lysis syndrome in 2010.

Morie A Gertz1.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20038233     DOI： 10.3109/10428190903488788

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  6 in total

1.  Effectiveness of a single fixed dose of rasburicase 3 mg in the management of tumour lysis syndrome.

Authors:  John Coutsouvelis; Meredith Wiseman; Lisa Hui; Susan Poole; Michael Dooley; Sushrut Patil; Sharon Avery; Andrew Wei; Andrew Spencer
Journal:  Br J Clin Pharmacol       Date:  2013-02       Impact factor: 4.335

Review 2.  Tumor Lysis Syndrome in Metastatic Colon Cancer Following Treatment with Regorafenib.

Authors:  Bilal Farooqi; Josh Simmons; Zhonglin Hao
Journal:  J Gastrointest Cancer       Date:  2015-09

Review 3.  The tumor lysis syndrome.

Authors:  Scott C Howard; Deborah P Jones; Ching-Hon Pui
Journal:  N Engl J Med       Date:  2011-05-12       Impact factor: 91.245

4.  A pharmacokinetic/pharmacodynamic model of tumor lysis syndrome in chronic lymphocytic leukemia patients treated with flavopiridol.

Authors:  Jia Ji; Diane R Mould; Kristie A Blum; Amy S Ruppert; Ming Poi; Yuan Zhao; Amy J Johnson; John C Byrd; Michael R Grever; Mitch A Phelps
Journal:  Clin Cancer Res       Date:  2013-01-08       Impact factor: 12.531

5.  Supportive methods for childhood acute lymphoblastic leukemia then and now: A compilation for clinical practice.

Authors:  Alexandra Podpeskar; Roman Crazzolara; Gabriele Kropshofer; Petra Obexer; Evelyn Rabensteiner; Miriam Michel; Christina Salvador
Journal:  Front Pediatr       Date:  2022-09-12       Impact factor: 3.569

6.  Tuberculosis and Tumor Lysis Syndrome-Coincidence or Coexistent: A Case Report.

Authors:  Viresh Swami; A V Lalitha; T K Anjan Kumar
Journal:  Indian J Crit Care Med       Date:  2020-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.